Issue 4, 2014

4-Chlorocolchicine derivatives bearing a thiourea side chain at the C-7 position as potent anticancer agents

Abstract

A series of 4-substituted colchicine derivatives were synthesized and evaluated with an eye toward developing new anticancer agents. As a result, 4-chlorocolchicine derivatives bearing a thioureide side chain at the C-7 position were found to exhibit significant cytotoxicities to three human cancer cell lines (A549, HT-29, and HCT116). In particular, compound 26 having an ethylthioureide group at the C-7 had high antitumor activity in vivo and a broad effective dosage range. Furthermore, compound 58, which has a (5-methylpyrazol-3-yl)thioureide group at the C-7 side chain, exhibited strong cytotoxicity and desirable metabolic stability in vitro.

Graphical abstract: 4-Chlorocolchicine derivatives bearing a thiourea side chain at the C-7 position as potent anticancer agents

Supplementary files

Article information

Article type
Concise Article
Submitted
30 Sep 2013
Accepted
20 Dec 2013
First published
07 Feb 2014

Med. Chem. Commun., 2014,5, 452-458

4-Chlorocolchicine derivatives bearing a thiourea side chain at the C-7 position as potent anticancer agents

H. Nishiyama, M. Ono, T. Sugimoto, T. Sasai, N. Asakawa, S. Ueno, Y. Tominaga, T. Yaegashi, M. Nagaoka, T. Matsuzaki, N. Kogure, M. Kitajima and H. Takayama, Med. Chem. Commun., 2014, 5, 452 DOI: 10.1039/C3MD00287J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements